(Q33818746)

English

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial (English)

1 reference

Europe PubMed Central

29 July 2017

phase I clinical trial

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Stephanie E. Combs

object named as

Stephanie E Combs

1

0 references

9

object named as

Jürgen Debus

1 reference

Europe PubMed Central

29 July 2017

author name string

Daniel Habermehl

2

1 reference

Europe PubMed Central

29 July 2017

Tom Ganten

3

1 reference

Europe PubMed Central

29 July 2017

Jan Schmidt

4

1 reference

Europe PubMed Central

29 July 2017

Lutz Edler

5

1 reference

Europe PubMed Central

29 July 2017

Iris Burkholder

6

1 reference

Europe PubMed Central

29 July 2017

Oliver Jäkel

7

1 reference

Europe PubMed Central

29 July 2017

Thomas Haberer

8

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

12 February 2011

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

11

1 reference

Europe PubMed Central

29 July 2017

67

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-67

0 references

Epidemiology of hepatocellular carcinoma in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Proton beam therapy for aged patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Particle radiation therapy using proton and heavier ion beams

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Correlation between initial chromatid damage and survival of various cell lines exposed to heavy charged particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Proton beam therapy for hepatocellular carcinoma with limited treatment options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Overview of clinical experiences on carbon ion radiotherapy at NIRS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Extracranial stereotactic radiation delivery: expansion of technology beyond the brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

The use of 3-D dose volume analysis to predict radiation hepatitis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045987

4 July 2018

https://api.crossref.org/works/10.1186%2F1471-2407-11-67

21 January 2018

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-67

21 January 2018

Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-67

21 January 2018

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated proton beam therapy for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and initial chromatid breakage in normal and tumour cells exposed in vitro to gamma rays and carbon ions at the HIRFL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21314962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-67

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33818746&oldid=2018553703"